- Side-effect information has different evidence categories: common adverse reactions, warnings, contraindications, and postmarketing reports.
- The current Wegovy prescribing information applies to that approved product and its labeled population; it is not evidence for a compounded preparation.
- Do not use a blog to diagnose a reaction or decide whether to start, stop, or change treatment.
- Questions about a prescription belong with the prescribing provider and dispensing pharmacy. Urgent concerns need professional or emergency help.
Four safety-information categories
A safety page is easier to read when each statement is labeled. Common adverse reactions are events observed in the studied product and population. Warnings describe important risks that require attention. Contraindications identify situations in which the labeled product should not be used. Postmarketing reports describe events reported after broader use; a report is not automatically proof of causation.
Those categories answer different questions. A list of possible reactions is not a diagnosis, a prediction, or an instruction for treating symptoms.
What an approved label can tell you
The current FDA Wegovy prescribing information is a product-specific source. It contains the approved product’s labeled indications, warnings, contraindications, adverse reactions, and other prescribing information. Read it as the label for Wegovy, not as evidence for a compounded semaglutide preparation.
FDA’s information on unapproved GLP-1 drugs explains that compounded drugs are not reviewed by FDA for safety, effectiveness, or quality before marketing. It also directs patients with questions about instructions or labels to their doctor, compounder, or telehealth platform. Kind MD does not infer a product-specific safety result from this article.
Questions for your provider
- Which product and label apply to my prescription?
- Which symptoms or changes should I report to my prescribing provider?
- Who should answer a question about the dispensing label or pharmacy materials?
- Which information is known for the approved product, and what is not established for a compounded preparation?
Do not start, stop, change, measure, store, or administer a prescription from a blog. If you are worried about a serious or urgent reaction, contact a qualified healthcare professional or emergency services as appropriate.
Kind MD is a telehealth platform that connects eligible patients with licensed healthcare providers who may prescribe compounded semaglutide or tirzepatide when clinically appropriate. The information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Bring your questions to a licensed provider.
Start with information for a provider to review.
Take the Free Quiz →